The Ebiosea Project aims to design an effective model of marine bioprospecting which not only takes into consideration the sustainability of natural resources but strives to ecologically exploit marine resources.

        The Ebiosea Project has identified 1.500 marine organisms potentially exploitable.




By means of careful planning and research, the Ebiosea Project evaluates the great potential of marine organisms as sources of active compounds that can in turn be successfully applied to human and animal health. Through experimental investigation, the Ebiosea Project has already confirmed the potential of marine biodiversity in supplying an array of novel natural active ingredients for nutraceutical development.

The active compounds found so far range in their origin from teleost and cartilaginous fishes, bivalve and cephalopod molluscs to macro-algae. These have resulted in an extensive portfolio of new compounds and we currently hold several patents with proven therapeutic properties published in international scientific journals.


The main objectives of the Ebiosea Project include:

• Comprehensive literature research on all potentially exploitable related marine resources.
• Search for active compounds of marine origin with beneficial properties for health.
• Development of an extensive database of marine specimens classified mainly by their potential therapeutic properties.
• Primary screening of isolated species found in the database through scientific experimental protocols which include an array of assays, isolation and elucidation of the structures of their active compounds.
• The development of marine compounds into commercial nutraceuticals applied to human and animal health.
• International academic and institutional collaborations for the ethical practice of marine bioprospecting.
• Marine ecology consultancy services.

Ebiotec continuously invests in the Research & Development of new products and conducts SCIENTIFIC STUDIES to prove their beneficial properties.